Question 1

Does Brevan Howard Capital Management own CDNA stock?

Accepted Answer

No. Brevan Howard Capital Management exited its CDNA (CareDx) position in Q2 2026. Its Q1 2026 13F listed 17,604 shares worth $305,605.

Question 2

How many shares of CDNA does Brevan Howard Capital Management own?

Accepted Answer

None since Q2 2026, when Brevan Howard Capital Management exited the position. Its Q1 2026 13F listed 17,604 shares worth $305,605.

Question 3

What is Brevan Howard Capital Management's CDNA position worth?

Accepted Answer

Brevan Howard Capital Management's CDNA position was worth $305,605 in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Brevan Howard Capital Management buying or selling CDNA?

Accepted Answer

In Q2 2026, Brevan Howard Capital Management exited its entire CDNA position.

Question 5

When did Brevan Howard Capital Management first buy CDNA?

Accepted Answer

Brevan Howard Capital Management first reported CDNA in its Q4 2023 13F and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$28.50	0
2026-Q1	Decreased	17,604	-16.3%	$305,605	0.0%	$17.36	0
2025-Q4	New	21,022	—	$396,054	0.0%	$18.84	33
2024-Q4	Exited	0	-100.0%	$0	0.0%	$21.41	0
2024-Q3	Decreased	6,665	-81.8%	$208,115	0.0%	$31.23	0